Prospective Observational Study to Assess Effectiveness and Safety of Intravenous Ferric Carboxymaltose 1000 mg in Patients of Chronic Heart Failure with Iron DeficiEncy - PRIDE-HF Study. Cardiology and Cardiovascular Medicine, v. 7, n. 6, p. 349–354, 5 Dec.2023.